The effect of genotype on sensitivity to inflammatory nociception: Characterization of resistant (A/J) and sensitive (C57BL/6J) inbred mouse strains

Pain

Volumn 76, Issue 1-2, 1998, Pages 115-125

  Mogil, Jeffrey S ^a   Lichtensteiger, Carol A ^a   Wilson, Sonya G ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Genotype; Heritability; Inflammatory nociception; Pain sensitivity

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; GENETIC MODEL; GENOTYPE; HERITABILITY; INFLAMMATION; MOUSE; NOCICEPTION; NONHUMAN; PAIN THRESHOLD; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; FORMALDEHYDE; GENOTYPE; INFLAMMATION; MICE; MICE, INBRED A; MICE, INBRED C57BL; PAIN; PAIN MEASUREMENT; REACTION TIME; SPECIES SPECIFICITY; SWIMMING;

EID: 0031746094     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00032-3     Document Type: Article

References (85)

1. Aloisi A.M., Albonetti M.E., Carli G. Behavioral effects of different intensities of formalin pain in rats. Physiol. Behav. 58:1995;603-610.
2. Atchley W.R., Fitch W.M. Gene trees and the origins of inbred strains of mice. Science. 25:1991;554-558.
3. Bachiocco V., Scesi M., Morselli A.M., Carli G. Individual pain history and familial pain tolerance models: relationships to post-surgical pain. Clin. J. Pain. 9:1993;266-271.
4. Baran A., Shuster L., Eleftheriou B.E., Bailey D.W. Opiate receptors in mice: genetic differences. Life Sci. 17:1975;633-640.
5. Belknap J.K., Crabbe J.C. Chromosome mapping of gene loci affecting morphine and amphetamine responses in BXD recombinant inbred mice. Ann. N. Y. Acad. Sci. 654:1992;311-323.
6. Belknap J.K., Haltli N.R., Goebel D.M., Lamé M. Selective breeding for high and low levels of opiate-induced analgesia in mice. Behav. Genet. 13:1983;383-396.
7. Belknap J.K., Noordewier B., Lamé M. Genetic dissociation of multiple morphine effects among C57BL/6J, DBA/2J and C3H/HeJ inbred mouse strains. Physiol. Behav. 46:1989;69-74.
8. Belknap J.K., Lamé M., Danielson P.W. Inbred strain differences in morphine-induced analgesia with the hot plate assay: a reassessment. Behav. Genet. 20:1990;333-338.
9. Belknap J.K., Mogil J.S., Helms M.L., Richards S.P., O'Toole L.A., Bergeson S.E., Buck K.J. Localization to proximal Chromosome 10 of a locus influencing morphine-induced analgesia in crosses derived from C57BL/6 and DBA/2 mouse strains. Life Sci. 57:1995;PL117-124.
10. Blizard D.A. Recombinant-inbred strains: general methodological considerations relevant to the study of complex characters. Behav. Genet. 22:1992;621-633.
11. Brown D.M., Hughes B.O. Practical aspects of strain variation in relation to pharmacological testing. J. Pharm. Pharmacol. 14:1962;399-405.
12. Brown J.H., Kissel J.W., Lish P.M. Studies on the acute inflammatory response. I. Involvement of the central nervous system in certain models of inflammation. J. Pharmacol. Exp. Ther. 160:1968;231-242.
13. Chapman, C.R. and Turner, J.A., Psychological and psychosocial aspects of acute pain. In: J.J. Bonica (Ed.), The Management of Pain, Lea and Febiger, Philadelphia, PA, 1990, pp. 122-132.
14. Coderre T.J., Vaccarino A.L., Melzack R. Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res. 535:1990;155-158.
15. Dallel R., Raboisson P., Clavelou P., Saade M., Woda A. Evidence for a peripheral origin of the tonic nociceptive response to subcutaneous formalin. Pain. 61:1995;11-16.
16. Dickenson, A.H. and Sullivan, A.F., Peripheral origins and central modulation of subcutaneous formalin-induced activity of rat dorsal horn neurones, Neurosci. Lett., 83 (1987a) 207-211.
17. Dickenson, A.H. and Sullivan, A.F., Subcutaneous formalin-induced activity of dorsal horn neurones in the rat: differential response to an intrathecal opiate administered pre or post formalin, Pain, 30 (1987b) 349-360.
18. Edwards P.W., Zeichner A., Kuczmierczyk A.R., Boczkowski J. Familial pain models: the relationship between family history of pain and current pain experience. Pain. 21:1985;379-384.
19. Eidelberg E., Erspamer R., Kreinick C.J., Harris J. Genetically determined differences in the effects of morphine on mice. Eur. J. Pharmacol. 32:1975;329-336.
20. Elmer, G.I., Pieper, J.O., Negus, S.S. and Woods, J.H., Genetic variance in innate nociception and its relationship to the potency of morphine-induced analgesia in thermal and chemical tests, Pain, (1997) in press.
21. Falconer, D.S. and Mackay, T.F.C., Introduction to Quantitative Genetics, Vol. 4, Longman, Essex, 1996.
22. Friedman R., Murphy D., Persons W., McCaughran J.A. Jr. Genetic predisposition to hypertension, elevated blood pressure and pain sensitivity: a functional analysis. Behav. Brain Res. 12:1984;75-79.
23. Gerlai R. Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype? Trends Neurol. Sci. 19:1996;177-181.
24. Gora-Maslak G., McClearn G.E., Crabbe J.C., Phillips T.J., Belknap J.K., Plomin R. Use of recombinant inbred strains to identify quantitative trait loci in psychopharmacology. Psychopharmacology. 104:1991;413-424.
25. Haley J.E., Sullivan A.F., Dickenson A.H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 518:1990;218-226.
26. Hegmann J.P., Possidente B. Estimating genetic correlations from inbred strains. Behav. Genet. 11:1981;103-114.
27. Honkasalo M.-L., Kaprio J., Winter T., Heikkila K., Sillanpaa M., Koskenvuo M. Migraine and concomitant symptoms among 8167 adult twin pairs. Headache. 35:1995;70-78.
28. Indo Y., Tsurata Y., Karim M.A., Ohta K., Kawano T., Mitsubuchi H., Tonoki H., Awaya Y., Matsuda I. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat. Genet. 13:1996;485-488.
29. Ingram D.K., Corfman T.P. An overview of neurobiological comparisons in mouse strains. Neurosci. Biobehav. Rev. 4:1980;421-435.
30. Jacob J.J., Nicola M.-A., Michaud G., Vidal C., Prudhomme N. Genetic modulations of stress-induced analgesia in mice. Ann. N. Y. Acad. Sci. 467:1986;104-113.
31. Kampov-Polevoy A.B., Kasheffskaya O.P., Overstreet D.H., Rezvani A.H., Viglinskaya I.V., Badistov B.A., Seredenin S.B., Halikas J.A., Sinclair J.D. Pain sensitivity and saccharin intake in alcohol-preferring and -nonpreferring rat strains. Physiol. Behav. 59:1996;683-688.
32. Kavaliers M., Hirst M. Daily rhythms of analgesia in mice: effects of age and photoperiod. Brain Res. 279:1983;387-393.
33. Khanna J.M., Mayer J.M., Le A.D., Kalant H. Differential response to ethanol, pentobarbital and morphine in mice selectively bred for ethanol sensitivity. Alcohol. 1:1984;3-7.
34. Lander, E.S. and Botstein, D., Mapping complex genetic traits in humans: new methods using a complete RFLP linkage map, Cold Spring Harbor Symposia on Quantitative Biology, Vol. LI, Cold Spring Harbor Laboratory, 1986, pp. 49-62.
35. Lariviere W.R., Melzack R. The bee venom test: a new tonic-pain test. Pain. 66:1996;271-277.
36. Larner A.J., Moss J., Rossi M.L., Anderson M. Congenital insensitivity to pain: a 20 year follow up. J. Neurol. Neurosurg. Psychiatry. 57:1994;973-974.
37. Lester N., Lefebvre J., Keefe F. Pain in young adults: I. Relationship to gender and family pain history. Clin. J. Pain. 10:1994;282-289.
38. Mailis A., Wade J. Profile of Caucasian women with possible genetic predisposition to reflex sympathetic dystrophy: a pilot study. Clin. J. Pain. 10:1994;210-217.
39. Marek P., Yirmiya R., Liebeskind J.C. Strain differences in the magnitude of stress-induced analgesia correlate with brain opiate receptor concentration. Brain Res. 447:1988;188-190.
40. Marek P., Mogil J.S., Sternberg W.F., Panocka I., Liebeskind J.C. N-Methyl-D-aspartic acid (NMDA) receptor antagonist MK-801 blocks non-opioid stress-induced analgesia. II. Comparison across three swim stress paradigms in selectively bred mice. Brain Res. 578:1992;197-203.
41. Marek P., Mogil J.S., Belknap J.K., Sadowski B., Liebeskind J.C. Levorphanol and swim stress-induced analgesia in selectively bred mice: evidence for genetic commonalties. Brain Res. 608:1993;353-357.
42. Mathis C., Neumann P.E., Gershenfeld H., Paul S.M., Crawley J.N. Genetic analysis of anxiety-related behaviors and responses to benzodiazepine-related drugs in AXB and BXA recombinant inbred mouse strains. Behav. Genet. 25:1995;557-568.
43. Meller S.T., Lewis S.J., Brody M.J., Gebhart G.F. Age, strain and anesthetic dependent differences in the nociceptive responses produced by i.v. 5-HT in the rat. Brain Res. 587:1992;88-94.
44. Milne R.J., Gamble G.D. Habituation to sham testing procedures modifies tail-flick latencies: effects on nociception rather than vasomotor tone. Pain. 39:1989;103-107.
45. Mogil J.S., Belknap J.K. Sex and genotype determine the selective activation of neurochemically-distinct mechanisms of swim stress-induced analgesia. Pharmacol. Biochem. Behav. 56:1997;61-66.
46. Mogil, J.S. and Wilson, S.G., Nociceptive and morphine antinociceptive sensitivity of 129 and C57BL/6 inbred strains: implications for transgenic knock-out studies, Eur. J. Pain, 1 (1997) 293-297.
47. Mogil, J.S., Flodman, P., Spence, M.A., Sternberg, W.F., Kest, B., Sadowski, B., Liebeskind, J.C. and Belknap, J.K., Oligogenic determination of morphine analgesic magnitude: a genetic analysis of selectively bred mouse lines, Behav. Genet., 25 (1995a) 397-406.
48. Mogil, J.S., Marek, P., Flodman, P., Spence, M.A., Sternberg, W.F., Kest, B., Sadowski, B. and Liebeskind, J.C., One or two genetic loci mediate high opiate analgesia in selectively bred mice, Pain, 60 (1995b) 125-135.
49. Mogil, J.S., Sadowski, B. and Belknap, J.K., The role of the serotonin-1B receptor in genetic sensitivity to opiate analgesia in mice, Soc. Neurosci. Abstr., 21 (1995c) 1415.
50. Mogil, J.S., Kest, B., Sadowski, B. and Belknap, J.K., Differential genetic mediation of sensitivity to morphine in genetic models of opiate antinociception: influence of nociceptive assay, J. Pharmacol. Exp. Ther., 276 (1996a) 532-544.
51. Mogil, J.S., Sternberg, W.F., Balian, H., Liebeskind, J.C. and Sadowski, B., Opioid and non-opioid swim stress-induced analgesia: a parametric analysis in mice, Physiol. Behav., 59 (1996b) 123-132.
52. Mogil, J.S., Sternberg, W.F., Marek, P., Sadowski, B., Belknap, J.K. and Liebeskind, J.C., The genetics of pain and pain inhibition, Proc. Natl. Acad. Sci. USA, 93 (1996c) 3048-3055.
53. Mogil, J.S., Richards, S.P., O'Toole, L.A., Helms, M.L., Mitchell, S.R. and Belknap, J.K., Genetic sensitivity to hot-plate nociception in DBA/2J and C57BL/6J inbred mouse strains: possible sex-specific mediation by δ2-opioid receptors, Pain, 70 (1997a) 267-277.
54. Mogil, J.S., Richards, S.P., O'Toole, L.A., Helms, M.L., Mitchell, S.R., Kest, B. and Belknap, J.K., Identification of a sex-specific quantitative trait locus mediating non-opioid stress-induced analgesia in female mice, J. Neurosci., 17 (1997b) 7995-8002.
55. Murray C.W., Cowan A., Larson A.A. Neurokinin and NMDA antagonists (but not a kainic acid antagonist) are antinociceptive in the mouse formalin model. Pain. 44:1991;179-185.
56. Nagase C.S., Randich A., Brush F.R. Genetic differences in avoidance behavior: cardiovascular activity, pain sensitivity and stress-induced analgesia. Peptides. 6:1985;29-35.
57. Nesbitt M.N., Skamene E. Recombinant inbred mouse strains derived from A/J and C57BL/6J: a tool for the study of genetic mechanisms in host resistance to infection and malignancy. J. Leukocyte Biol. 36:1984;357-364.
58. Nothdurft R.E., Watson G.S., Sufka K.J., Mogil J.S. Optimal scoring strategies for the mouse formalin test. Soc. Neurosci. Abstr. 23:1997;162.
59. 2+ channel gene CACNL1A4. Cell. 87:1996;543-552.
60. Peterson M.A., Basbaum A.I., Abbadie C., Rohde D.S., McKay W.R., Taylor B.K. The differential contribution of capsaicin-sensitive afferents to behavioral and cardiovascular measures of brief and persistent nociception and to Fos expression in the formalin test. Brain Res. 755:1997;9-16.
61. Porro C.A., Cavazzuti M. Spatial and temporal aspects of spinal cord and brainstem activation in the formalin pain model. Prog. Neurobiol. 41:1993;565-607.
62. Postacchini F., Lami R., Pugliese O. Familial predisposition to discogenic low-back pain. Spine. 13:1988;1403-1406.
63. Puig S., Sorkin L.S. Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain. 64:1995;345-355.
64. Ramabadran K. Strain differences in the hyperalgesic effect of a novel κ receptor agonist, U-50,488H in mice. Eur. J. Pharmacol. 98:1984;425-427.
65. Ramabadran K., Michaud G., Jacob J.J.C. Genetic influences on the control of nociceptive responses and precipitated abstinence in mice. Ind. J. Exp. Biol. 20:1982;74-76.
66. Rosecrans J.A., Robinson S.E., Johnson J.H., Mokler D.J., Hong J.-S. Neuroendocrine, biogenic amine and behavioral responsiveness to a repeated foot-shock-induced analgesia (FSIA) stressor in Sprague-Dawley (CD) and Fischer-344 (CDF) rats. Brain Res. 382:1986;71-80.
67. Rosland J.H., Tjolsen A., Maehle B., Hole K. The formalin test in mice: effect of formalin concentration. Pain. 42:1990;235-242.
68. Saavedra J.M. Spontaneously (genetic) hypertensive rats: naloxone-reversible and propranolol-reversible decrease in pain sensitivity. Experientia. 37:1981;1002-1003.
69. Shir Y., Raber P., Devor M., Seltzer Z. Mechano- and thermo-sensitivity in rats genetically prone to developing neuropathic pain. NeuroReport. 2:1991;313-316.
70. Shuster L., Webster G.W., Yu G., Eleftheriou B.E. A genetic analysis of the response to morphine in mice: analgesia and running. Psychopharmacologia (Berl.). 42:1975;249-254.
71. Sitsen J.M.A., De Jong W. Hypoalgesia in genetically hypertensive rats (SHR) is absent in rats with experimental hypertension. Hypertension. 5:1983;185-190.
72. Sudakov S.K., Goldberg S.R., Borisova E.V., Surkova L.A., Turina I.V., Rusakov D.J., Elmer G.I. Differences in morphine reinforcement property in two inbred rat strains: associations with cortical receptors, behavioral activity, analgesia and the cataleptic effects of morphine. Psychopharmacology. 112:1993;183-188.
73. Taylor B.A. Genetic relationships between inbred strains of mice. J. Hered. 63:1972;83-86.
74. Taylor B.K., Peterson M.A., Basbaum A.I. Persistent cardiovascular and behavioral nociceptive responses to subcutaneous formalin require peripheral nerve input. J. Neurosci. 15:1995;7575-7584.
75. Taylor B.K., Peterson M.A., Basbaum A.I. Early nociceptive events influence the temporal profile, but not the magnitude, of the tonic response to subcutaneous formalin: effects with remifentanil. J. Pharmacol. Exp. Ther. 280:1997;876-883.
76. Thrush D.C. Congenital insensitivity to pain: a clinical, genetic and neurophysiological study of four children from the same family. Brain. 96:1973;369-386.
77. Tjolsen A., Berge O.-G., Hunskaar S., Rosland J.H., Hole K. The formalin test: an evaluation of the method. Pain. 51:1992;5-17.
78. Trullas R., Skolnick P. Differences in fear motivated behaviors among inbred mouse strains. Psychopharmacology. 111:1993;323-331.
79. Vaccarino A.L., Chorney D.A. Descending modulation of central neural plasticity in the formalin pain test. Brain Res. 666:1994;104-108.
80. Vaccarino A.L., Marek P., Liebeskind J.C. Stress-induced analgesia prevents the development of the tonic, late phase of pain produced by subcutaneous formalin. Brain Res. 572:1993;250-252.
81. Violon A., Giurgea D. Familial models for chronic pain. Pain. 18:1984;199-203.
82. Wheeler-Aceto H., Porreca F., Cowan A. The rat paw formalin test: comparison of noxious agents. Pain. 40:1990;229-238.
83. Woolf C.J. Evidence for a central component of post-injury pain hypersensitivity. Nature. 308:1983;686-688.
84. Woolfolk D.R., Holtzman S.G. Rat strain differences in the potentiation of morphine-induced analgesia by stress. Pharmacol. Biochem. Behav. 51:1995;699-703.
85. Yamamoto T., Yaksh T.L. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology. 77:1992;757-763.